105 related articles for article (PubMed ID: 7910152)
1. Molecular mechanisms possibly affecting WT1 function in human ovarian tumors.
Viel A; Giannini F; Capozzi E; Canzonieri V; Scarabelli C; Gloghini A; Boiocchi M
Int J Cancer; 1994 May; 57(4):515-21. PubMed ID: 7910152
[TBL] [Abstract][Full Text] [Related]
2. Constitutional and somatic mutations in the WT1 gene in Wilms' tumor patients.
Nordenskjöld A; Friedman E; Sandstedt B; Söderhäll S; Anvret M
Int J Cancer; 1995 Nov; 63(4):516-22. PubMed ID: 7591260
[TBL] [Abstract][Full Text] [Related]
3. Identification of the cellular protein encoded by the human Wilms' tumor (WT1) gene.
Telerman A; Dodemont H; Degraef C; Galand P; Bauwens S; Van Oostveldt P; Amson RB
Oncogene; 1992 Dec; 7(12):2545-8. PubMed ID: 1334252
[TBL] [Abstract][Full Text] [Related]
4. Analysis of the 11p13 Wilms' tumor suppressor gene (WT1) in ovarian tumors.
Bruening W; Gros P; Sato T; Stanimir J; Nakamura Y; Housman D; Pelletier J
Cancer Invest; 1993; 11(4):393-9. PubMed ID: 8324644
[TBL] [Abstract][Full Text] [Related]
5. Expression of the candidate Wilm's tumor gene, WT1, in human leukemia cells.
Miyagi T; Ahuja H; Kubota T; Kubonishi I; Koeffler HP; Miyoshi I
Leukemia; 1993 Jul; 7(7):970-7. PubMed ID: 8321047
[TBL] [Abstract][Full Text] [Related]
6. p53 mutations in ovarian tumors, detected by temperature-gradient gel electrophoresis, direct sequencing and immunohistochemistry.
Kappes S; Milde-Langosch K; Kressin P; Passlack B; Dockhorn-Dworniczak B; Röhlke P; Löning T
Int J Cancer; 1995 Feb; 64(1):52-9. PubMed ID: 7665249
[TBL] [Abstract][Full Text] [Related]
7. Analysis of WT1 in granulosa cell and other sex cord-stromal tumors.
Coppes MJ; Ye Y; Rackley R; Zhao XL; Liefers GJ; Casey G; Williams BR
Cancer Res; 1993 Jun; 53(12):2712-4. PubMed ID: 8504409
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of the remaining allele of the WT1 gene in a Wilms' tumour from a WAGR patient.
Brown KW; Watson JE; Poirier V; Mott MG; Berry PJ; Maitland NJ
Oncogene; 1992 Apr; 7(4):763-8. PubMed ID: 1314370
[TBL] [Abstract][Full Text] [Related]
9. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
10. The WT1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Maheswaran S; Englert C; Bennett P; Heinrich G; Haber DA
Genes Dev; 1995 Sep; 9(17):2143-56. PubMed ID: 7657166
[TBL] [Abstract][Full Text] [Related]
11. Alternative splicing and genomic structure of the Wilms tumor gene WT1.
Haber DA; Sohn RL; Buckler AJ; Pelletier J; Call KM; Housman DE
Proc Natl Acad Sci U S A; 1991 Nov; 88(21):9618-22. PubMed ID: 1658787
[TBL] [Abstract][Full Text] [Related]
12. Multiplex PCR screening detects small p53 deletions and insertions in human ovarian cancer cell lines.
Runnebaum IB; Tong XW; Moebus V; Heilmann V; Kieback DG; Kreienberg R
Hum Genet; 1994 Jun; 93(6):620-4. PubMed ID: 8005584
[TBL] [Abstract][Full Text] [Related]
13. Alteration of the p53 tumor suppressor gene occurs independently of K-ras activation and more frequently in serous adenocarcinomas than in other common epithelial tumors of the human ovary.
Fujita M; Enomoto T; Inoue M; Tanizawa O; Ozaki M; Rice JM; Nomura T
Jpn J Cancer Res; 1994 Dec; 85(12):1247-56. PubMed ID: 7852189
[TBL] [Abstract][Full Text] [Related]
14. Presence of Wilms' tumor gene (wt1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias.
Menssen HD; Renkl HJ; Rodeck U; Maurer J; Notter M; Schwartz S; Reinhardt R; Thiel E
Leukemia; 1995 Jun; 9(6):1060-7. PubMed ID: 7596170
[TBL] [Abstract][Full Text] [Related]
15. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
16. Genotype/phenotype correlations in Wilms' tumor.
Huff V
Med Pediatr Oncol; 1996 Nov; 27(5):408-14. PubMed ID: 8827067
[TBL] [Abstract][Full Text] [Related]
17. Genomic organization of the human WT1 gene.
Tadokoro K; Oki N; Fujii H; Ohshima A; Inoue T; Yamada M
Jpn J Cancer Res; 1992 Nov; 83(11):1198-203. PubMed ID: 1483934
[TBL] [Abstract][Full Text] [Related]
18. Regulated expression and potential roles of p53 and Wilms' tumor suppressor gene (WT1) during follicular development in the human ovary.
Makrigiannakis A; Amin K; Coukos G; Tilly JL; Coutifaris C
J Clin Endocrinol Metab; 2000 Jan; 85(1):449-59. PubMed ID: 10634423
[TBL] [Abstract][Full Text] [Related]
19. [Expression P53 protein and chromosome aberrations in benign tumors and ovarian carcinoma].
Kamiński K; Putowski L; Oleszczuk J
Ginekol Pol; 2003 Sep; 74(9):741-5. PubMed ID: 14674118
[TBL] [Abstract][Full Text] [Related]
20. Induction of rat WT1 gene expression correlates with human chromosome 11p11.2-p12-mediated suppression of tumorigenicity in rat liver epithelial tumor cell lines.
Coleman WB; Ricketts SL; Borchert KM; Presnell SC; Esch GL; McCullough KD; Weissman BE; Smith GJ; Grisham JW
Int J Oncol; 1999 May; 14(5):957-63. PubMed ID: 10200348
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
